{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:37:42Z","timestamp":1777390662729,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ajp.2020.102186","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T18:21:32Z","timestamp":1590690092000},"page":"102186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Identification of risk factors and metabolic monitoring practices in patients on antipsychotic drugs in South India"],"prefix":"10.1016","volume":"53","author":[{"given":"Pooja Gopal","family":"Poojari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohil A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leelavathi D.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahana","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swarnali","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshava","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayanarayana","family":"Kunhikatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Thunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajp.2020.102186_bib0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes care"},{"key":"10.1016\/j.ajp.2020.102186_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajp.2014.08.002","article-title":"Antipsychotic treatment of schizophrenia: an update","volume":"11","author":"Bruijnzeel","year":"2014","journal-title":"Asian J. Psychiatr."},{"issue":"8","key":"10.1016\/j.ajp.2020.102186_bib0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/070674370605100804","article-title":"Metabolic monitoring for patients treated with antipsychotic medications","volume":"51","author":"Cohn","year":"2006","journal-title":"Can. J. Psychiatry."},{"issue":"2","key":"10.1016\/j.ajp.2020.102186_bib0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4103\/psychiatry.IndianJPsychiatry_64_16","article-title":"Prevalence and predictors of metabolic syndrome in schizophrenia patients from Assam","volume":"59","author":"Das","year":"2017","journal-title":"Indian. J. Psychiatry."},{"issue":"1","key":"10.1016\/j.ajp.2020.102186_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-0179-2-14","article-title":"Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study","volume":"2","author":"De Hert","year":"2006","journal-title":"Clin.Pract. Epidemiol. Ment. Health."},{"key":"10.1016\/j.ajp.2020.102186_bib0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajp.2019.08.010","article-title":"Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey","volume":"45","author":"Dong","year":"2019","journal-title":"Asian J. Psychiatr"},{"issue":"5","key":"10.1016\/j.ajp.2020.102186_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0019-5545.196973","article-title":"Clinical practice guidelines for management of schizophrenia","volume":"59","author":"Grover","year":"2017","journal-title":"Indian.J.Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2020.102186_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pcd.2008.10.005","article-title":"Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications","volume":"3","author":"Hasnain","year":"2009","journal-title":"Prim. Care. Diabetes"},{"issue":"5","key":"10.1016\/j.ajp.2020.102186_bib0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/10398561003731189","article-title":"Promoting physical health in youth mental health services: ensuring routine monitoring of weight and metabolic indices in a first episode psychosis clinic","volume":"18","author":"Hetrick","year":"2010","journal-title":"Australas.Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2020.102186_bib0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1039856215604484","article-title":"Improving metabolic monitoring in patients maintained on antipsychotics in Penang","volume":"24","author":"Hor","year":"2016","journal-title":"Malaysia. Australas. Psychiatry."},{"issue":"41","key":"10.1016\/j.ajp.2020.102186_bib0055","first-page":"1","article-title":"Longitudinal and age trends of metabolic syndrome and its risk factors: The Family Heart Study","volume":"3","author":"Kraja","year":"2006","journal-title":"Nutr. Metab"},{"key":"10.1016\/j.ajp.2020.102186_bib0060","article-title":"Clinical practice guidelines for the management of schizophrenia","author":"Kulhara","year":"2005","journal-title":"Indian psychiatric society treatment guidelines"},{"issue":"3","key":"10.1016\/j.ajp.2020.102186_bib0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/2231-0738.99477","article-title":"A retrospective study of the metabolic adverse effects of antipsychotics, antidepressants, and mood stabilizers in the psychiatry outpatient clinic of a tertiary care hospital in south India","volume":"2","author":"Lahon","year":"2012","journal-title":"Int.J.Nutr. Pharmacol.Neurol. Dis."},{"issue":"7","key":"10.1016\/j.ajp.2020.102186_bib0070","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1176\/ajp.2006.163.7.1273","article-title":"Prevalence of the metabolic syndrome among patients receiving clozapine","volume":"163","author":"Lamberti","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2020.102186_bib0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-004-1641-y","article-title":"Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study","volume":"48","author":"Mackin","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ajp.2020.102186_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-244X-7-28","article-title":"A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients","volume":"7","author":"Mackin","year":"2007","journal-title":"BMC psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.ajp.2020.102186_bib0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.12.487","article-title":"Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE schizophrenia trial: prospective data from phase 1","volume":"101","author":"Meyer","year":"2008","journal-title":"Schizophr.Res."},{"issue":"2","key":"10.1016\/j.ajp.2020.102186_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.9740\/mhc.2018.03.049","article-title":"Overcoming barriers to monitoring patients taking second-generation antipsychotics","volume":"8","author":"Pe\u00f1a","year":"2018","journal-title":"Ment. Health. Clin."},{"issue":"9","key":"10.1016\/j.ajp.2020.102186_bib0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/pch\/16.9.581","article-title":"Evidence-based recommendations for monitoring safety of second-generation antipsychotics in children and youth","volume":"16","author":"Pringsheim","year":"2011","journal-title":"Paediatr. Child. Health."},{"key":"10.1016\/j.ajp.2020.102186_bib0100","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.ajp.2019.03.009","article-title":"Bridging the efficacy-effectiveness gap in the antipsychotic treatment of schizophrenia: Back to the basics","volume":"40","author":"Ramesh","year":"2019","journal-title":"Asian J. Psychiatr."},{"issue":"11","key":"10.1016\/j.ajp.2020.102186_bib0105","first-page":"189","article-title":"Metabolic syndrome among patients with schizophrenia receiving antipsychotics at chitwan medical College, Nepal","volume":"6","author":"Sharma","year":"2016","journal-title":"Int. J. Health. Sci. Res."},{"key":"10.1016\/j.ajp.2020.102186_bib0110","series-title":"Metabolic Challenges in Mental Health. [Online] Uspharmacist.Com","author":"Tammie Lee Demler","year":"2017"},{"issue":"4","key":"10.1016\/j.ajp.2020.102186_bib0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5694\/j.1326-5377.2009.tb02344.x","article-title":"Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm","volume":"190","author":"Waterreus","year":"2009","journal-title":"Med.J.Aust."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201820302987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201820302987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:38:01Z","timestamp":1761755881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201820302987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":23,"alternative-id":["S1876201820302987"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2020.102186","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of risk factors and metabolic monitoring practices in patients on antipsychotic drugs in South India","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2020.102186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102186"}}